Treatment of congenital hypothyroidism: comparison between L-thyroxine oral solution and tablet formulations up to 3 years of age

Author:

Vigone Maria Cristina1,Ortolano Rita2,Vincenzi Gaia1,Pozzi Clara1,Ratti Micol1,Assirelli Valentina2,Vissani Sofia2,Cavarzere Paolo3,Mussa Alessandro4,Gastaldi Roberto5,Di Mase Raffaella6,Salerno Mariacarolina6,Street Maria Elisabeth7,Trombatore Jessica8,Weber Giovanna1,Cassio Alessandra2,_ _

Affiliation:

1. 1Department of Pediatrics, Endocrine Unit, Vita-Salute San Raffaele University, IRCSS San Raffaele, Milan, Italy

2. 2Sant’Orsola-Malpighi University Hospital, Pediatric Unit, Program of Pediatric Endocrinology, Bologna, Italy

3. 3Pediatric Department, Universitary Hospital of Verona, Verona, Italy

4. 4Department of Public Health and Pediatrics, University of Torino, Torino, Italy

5. 5Giannina Gaslini Children’s Hospital, Genoa, Italy

6. 6Department of Pediatrics, AOU Federico II, Naples, Italy

7. 7AUSL-IRCCS Reggio Emilia, Department of Pediatrics, Reggio Emilia, Italy

8. 8Department of Pediatrics, University of Messina, Messina, Italy

Abstract

Objective Oral solution and tablet formulations of levothyroxine (L-T4) are both used in the treatment of congenital hypothyroidism (CH). However, few studies and with a limited follow-up period have been published comparing these two formulations in children. Design The aim of this multicenter study was to compare the effectiveness of L-T4 oral solution (with ethanol as excipient) and tablet formulation in children with CH up to 3 years of age. Methods Children diagnosed with CH between 2006 and 2015 were enrolled and divided into two groups according to the L-T4 formulation used: solution in drops (group D) or tablets (group T). Auxological parameters, thyroid-stimulating hormone (TSH) and free thyroxine (FT4) values and L-T4 dose were collected at diagnosis and at 15 days, 1, 3, 6, 12, 24 and 36 months of treatment. The developmental quotient (DQ) at 1 and 3 years of age was evaluated using Griffiths’ Scale. Results In this study, 254 children were enrolled among which 117 were treated with solution and 137 with tablets. Auxological parameters, dose and thyroid function values at diagnosis, 3, 6, 12, 24, 36 months were not significantly different. TSH at 15 days (P = 0.002) and 1 month (P = 0.009) was significantly reduced in group D. At 2-year follow-up, median TSH was significantly lower in group T (P = 0.03). No statistical difference was detected between the median DQ; however, group D showed lower values in the language subscale at 12 months and in eye–hand coordination at 36 months. Conclusions Both therapeutic strategies are effective in the treatment of CH. A higher risk of overtreatment in the first months of therapy seems to be associated with oral solution L-T4; therefore, a different strategy should be considered when starting and adjusting the dose. No negative effects on cognitive development were observed. The data obtained are encouraging but long-term follow-up is needed.

Publisher

Bioscientifica

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3